The company reached definitive agreements to issue 989,301 ordinary shares along with warrants to purchase an additional 1,483,952 shares. Each unit is priced at $3.74, with warrants exercisable immediately upon issuance and valid for five years following the effective registration of the underlying shares. H.C. Wainwright & Co. and Rodman & Renshaw LLC are managing the transaction as exclusive joint placement agents.
In section Releases
CollPlant Raises $3.7 Million to Advance Laser Supercomputing
Rehovot-based CollPlant Biotechnologies has secured $3.7 million through a private placement of shares and warrants, drawing primarily from its existing investor base. The funding is earmarked to accelerate the development of proprietary laser-based supercomputing architecture and Laser Processing Unit technology under its subsidiary, LightSolver.
CollPlant expects the deal to close around October 14, 2026, pending standard closing conditions. Beyond R&D for LightSolver, the firm intends to allocate a portion of the capital toward general corporate purposes and working capital. This move underscores the company's dual focus on its origins in regenerative medicine and its recent expansion into deep-tech photonic computing.
Comments (0)
No comments yet. Be the first!